Novel treatment strategies for patients with CML who are intolerant or resistant to available TKIs
11 months ago
[{"url":"https://i.ytimg.com/vi/vrWKGWXoxNI/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLALFSfSKKicYFafT_49436HwxD1kw","width":360,"height":202},{"url":"https://i.ytimg.com/vi/vrWKGWXoxNI/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLCmlKb3yBC7sra2RMjLx1yuRzh9-w","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/vrWKGWXoxNI/mqdefault_6s.webp?du=3000&sqp=CKS4sKkG&rs=AOn4CLBRwHaYtCYFFKt4Wg2YElYwxzf9FQ","width":320,"height":180}
[{"text":"Valentin Garcia Guti\u00e9rrez, MD, PhD, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain, discusses the necessity to develop\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Novel treatment strategies for patients with CML who are intolerant or resistant to available TKIs by VJHemOnc \u2013 Video Journal of Hematological Oncology 60 views 11 months ago 2 minutes","duration":"2 minutes"}